Print Page  Close Window

SEC Filings

8-K
MYOKARDIA INC filed this Form 8-K on 05/09/2019
Entire Document
 

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share amounts)

(Unaudited)

 

 

 

Three Months Ended

March 31,

 

 

 

2019

 

 

2018

 

Collaboration and license revenue

 

$

 

 

$

5,331

 

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

 

26,190

 

 

 

16,618

 

General and administrative

 

 

13,551

 

 

 

7,313

 

Total operating expenses

 

 

39,741

 

 

 

23,931

 

Loss from operations

 

 

(39,741

)

 

 

(18,600

)

Interest and other income, net

 

 

2,271

 

 

 

780

 

Net loss

 

 

(37,470

)

 

 

(17,820

)

Other comprehensive gain (loss)

 

 

363

 

 

 

(137

)

Comprehensive loss

 

$

(37,107

)

 

$

(17,957

)

Net loss per share, basic and diluted

 

$

(0.93

)

 

$

(0.50

)

Weighted average number of shares used to compute net loss

   per share, basic and diluted

 

 

40,506,313

 

 

 

35,827,235